The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?

The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?

One major complication after fistulating glaucoma surgeries are fibroblast-mediated scarring processes and their specific prevention is key in the development of novel pharmaceutical concepts. Within this study a possible antifibrotic potential of kitasamycin (KM) in a transforming growth factor (TG...

Full description

Bibliographic Details
Main Authors: Katharina A. Sterenczak, Georg Fuellen, Anselm Jünemann, Rudolf F. Guthoff, Oliver Stachs, Thomas Stahnke
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Pharmaceutics
Subjects:
glaucoma surgery
fibrosis
kitasamycin
novel pharmaceutical concepts
specific antifibrotic agent
Online Access:https://www.mdpi.com/1999-4923/15/2/329

Internet

https://www.mdpi.com/1999-4923/15/2/329

Similar Items